RE:RE:AACR
Paul is NOT an entrepreneur, he's a big pharma big spending big budget guy he's not good at promoting his company. He his a rooky in finance and totally relies on his lame CFO for the financings and even worse IR now. I heard that that Gary Littlejohn is actually helping us in keeping the big spender in check. The science team is the best part of the company but is learning the ropes and taking longer than i should, 14 months for a MTD. Also more patients in P1b should mean longer timeline too.. they never say those things, do they.